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This is an official
CDC HEALTH ADVISORY
Interim Guidance for Institutions or Organizations Hosting Persons 
Arriving in the United States from Areas with Severe Acute Respiratory 
Syndrome (SARS)
To date, most reported cases of Severe Acute Respiratory Syndrome (SARS) in the United States have been acquired during 
international travel to countries where SARS is being transmitted in the community. (These areas are described at case 
definition page). In this country, only a small number of suspected or probable cases of SARS have been detected among 
exposed healthcare personnel and household contacts of SARS patients. Casual contact with SARS patients at schools, other 
institutions, or public gatherings (e.g., attending the same class or meeting) has not resulted in documented transmission in 
the United States.
Thousands of people arrive in the United States from areas where SARS outbreaks are occurring to participate in gatherings 
such as academic courses, business meetings, or sporting events. Guidance is needed to provide a consistent, rational 
approach to SARS prevention without unnecessarily stigmatizing these groups or interfering with collegial pursuits, commerce, 
and other important activities.
A t th is time, CDC does not recommend canceling or postponing classes, meetings or other gatherings that w ill 
include persons traveling to the United States from  areas w ith SARS. CDC is working closely with WHO and other 
partners as part of a global collaboration to address the SARS outbreak. The following comprehensive activities are taking 
place to prevent importation and spread of SARS from inbound passengers:
• Stringent outbreak control measures, including isolation of SARS patients and quarantine of their exposed contacts, in
countries with SARS;
• Pre-embarkation screening of persons traveling from areas with SARS to defer travel for those with symptoms or signs
of SARS or exposure to known SARS patients in the past 10 days;
• Assessment by health authorities of ill persons aboard arriving flights from an area with SARS to ensure that ill
passengers are isolated and evaluated promptly upon arrival and that appropriate follow-up of other passengers 
occurs, as necessary;
• Distribution of health alert notices to travelers arriving in the United States from areas with SARS to notify them of the
importance of monitoring their health closely for a period of 10 days following departure, and for persons who develop 
fever or respiratory symptoms, the need to promptly seek medical evaluation; and
• Rapid detection and isolation of persons in the United States who have traveled from an area with SARS and have
symptoms compatible with early suspected SARS within 10 days of arrival.
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At th is time, CDC does not recommend quarantine o f persons arriving from  areas w ith SARS.
The following are interim recommendations to assist persons who are organizing gatherings of students and other persons 
traveling to the United States from areas with SARS, including gatherings in academic settings, business meetings, or sporting 
events, etc. These recommendations are based on the experience in the United States to date and may be revised as more 
information about the SARS situation in the United States and globally becomes available.
If organization representatives become aware of a person from an area with SARS who develops fever or respiratory 
symptoms, the following steps should be taken:
1. Exclude the ill person from activities (e.g., classes, meetings, and other public areas) and locate in a separate area to
minimize contact with other people while awaiting further medical evaluation.
2. Alert appropriate healthcare personnel that an individual from an area with SARS requires evaluation, so that advance 
preparations can be made to implement infection control procedures to prevent transmission to others during transport 
and in the healthcare setting.
3. Remind the treating healthcare provider to notify the appropriate state or local health officials 
(http://www.cdc.gov/states.htm) if SARS is suspected. Further information for healthcare providers about the 
management of persons with suspected SARS is available at http://www.cdc.gov/ncidod/sars/exposuremanagement.htm
Organizations that would like to take additional steps should consider the following actions:
1. Send basic information about SARS, including information in the health alert notice and a reminder about the
importance of hand hygiene, to the participants before departure (by email, for example).
2. Notify the participants (prior to departure) that persons traveling from areas with SARS with fever or respiratory
symptoms or exposure to SARS patients within 10 days prior to scheduled departure should not travel and should 
seek medical evaluation.
3. Contact state or local public health officials (link to list of state and some local health departments) before the event,
and collaborate to ensure that appropriate public health guidelines are followed.
4. Include basic information about SARS, including the information in the health alert notice and a reminder about the
importance of hand hygiene, in the orientation or meeting registration packet.
5. Give participants tools for self-monitoring, which may include a complimentary thermometer, a temperature log, and
contact information, as well as alcohol-based hand rubs for hand hygiene.
6. Work with state or local public health officials to identify an emergency room or other healthcare facility where an ill
visitor may be evaluated and where recommended infection control measures can be followed, and/or arrange for 
healthcare providers to be available on site.
7. Establish a health information hotline or website.
8. Screen participants to identify those at high risk for SARS; sample questions that may be useful include:
• In the past 10 days, have you been in an area with SARS?
• If so, do you have any of the following symptoms: fever, cough, difficulty breathing, or shortness of breath?
• In the past 10 days, have you had close contact with any person who has been diagnosed with SARS? (Close 
contact is defined as caring for or living with someone with SARS, or having direct contact with infectious 
material such as respiratory secretions from a person who has SARS.)
Work with local and state public health officials to determine where patients with SARS (who do not medically require 
hospitalization) will be housed until their symptoms resolve. (Persons should be hospitalized unless they can be housed in a 
designated residential facility for isolation of convalescing cases where recommended infection control measures can be 
followed.)
The Centers fo r  Disease C ontro l and Prevention (CDC) p ro tec ts  people 's hea lth  and  sa fe ty  by p reven ting  and  
contro lling  diseases and  in ju rie s ; enhances hea lth  decisions by p rov id ing  credib le in fo rm a tion  on c ritica l health  
issues; and  prom otes hea lthy liv in g  th rough s trong  partnersh ips w ith  loca l, na tiona l and  in te rna tiona l
organizations.
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